ColumbiaMagazine.com
Printed from:

Welcome to Columbia Magazine  
 



































 
WKU researcher using basil to combat cancer

Dr. Chandra Emani and students are genetically engineering basil to produce more eugenol, a compound with medicinal value and is believed to help control breast cancer. 'Plants are a storehouse of chemicals which can treat anything that's inflamed. Inflammation is the basis for cancer so if we can find plant based treatment it may not be painful medical process anymore. It's just we have this plant we can include in the diet at the very early stages and ward off inflammation that would otherwise lead to cancer.' - Dr. Chandra Emani
Click on headline for complete story with photo(s)

From Western Kentucky University

OWENSBORO, Ky. - Plants that may help fight breast cancer are sprouting and taking root in a Western Kentucky University biology faculty member's laboratory at the Owensboro Centre for Business and Research.

Dr. Chandra Emani, assistant professor of plant molecular biology at WKU-Owensboro, is conducting research on the pharmaceutical and therapeutic benefits of the basil plant (ocimum sp.), the herb widely known for its medicinal and culinary uses.



Basil has long been used in the east as a supplemental treatment

"If you look at the east, they've been using the plant not exactly as a medication but a supplement for a lot of treatments," he said. "Basil is a plant which has a lot of compounds called metabolites, meaning the leaves of a basic basil plant, like any other plant, make a lot of stuff."

In his lab at the Owensboro facility, Dr. Emani and his students are genetically engineering the basil to produce more eugenol, a compound in basil that "has a very great pharmaceutical value because it's shown to control breast cancer."

Grinding basil leaves produces a compound called eugenol

"When you grind these basil leaves there is a compound called eugenol that comes out," said Dr. Emani, who received a $12,000 Research and Creative Activities Program (RCAP) grant from WKU's Office of Research. "Eugenol, when they put it on a plate where there are tumor cells, it stopped growth of the tumor cells. That was a proof of concept experiment which was done a long time back."

Through his research at the Owensboro center, Dr. Emani is continuing to build the proof of concept that basil could produce a useful plant-based pharmaceutical to treat breast cancer.

"If I make it make higher and higher amounts of eugenol, that plant, basil plant, will be a storehouse of that anti-cancerous compound," he said.

Next phase would be a research project to test for cancer treatment value

The next phase in the research project would be to test the compound as an effective cancer treatment. "If I can show it stops breast cancer growth, I have now an environmentally friendly plant-based treatment for breast cancer," Dr. Emani said.

With those results, Dr. Emani would then be able to seek funding from other research agencies for clinical trials "to see if this is an effective way to get a pharmaceutical compound from a plant."

Owensboro cancer research program focuses on plant-based pharmaceuticals

Dr. Emani's project aims at complementing the efforts of groups in the Owensboro cancer research program that are utilizing plant-based pharmaceuticals in cancer treatment.

"Plants are a storehouse of chemicals which can treat anything that's inflamed," he said. "Inflammation is the basis for cancer so if we can find plant based treatment it may not be painful medical process anymore. It's just we have this plant we can include in the diet at the very early stages and ward off inflammation that would otherwise lead to cancer."

Besides combatting cancer, research project increases undergraduate opportunities

In addition to combatting cancer and improving the community's health, the research project is increasing the undergraduate research opportunities offered through WKU-Owensboro, Dr. Emani said.

Dr. Emani, who earned his bachelor's, master's and doctoral degrees in India, has been at WKU-Owensboro since 2010 and has seen the number of students taking his courses and working in the research lab grow from two to 15.

By taking advantage of WKU's FUSE (Faculty-Undergraduate Student Engagement) grants, his students are becoming full-fledged researchers and preparing themselves for graduate schools. And by working in his lab and with partners like Hollison Technologies and Kentucky BioProcessing, his students are gaining real-world experience in plant-based genetic engineering.

"We want to deal with treating cancer in a very holistic way, what I mean is we want to find one treatment that takes care of many cancers," he said.



This story was posted on 2014-01-16 14:28:46
Printable: this page is now automatically formatted for printing.
Have comments or corrections for this story? Use our contact form and let us know.



Dr. Chandri Emani works on therapeutic properties of basil



2014-01-16 - WKU/Owensboro - Photo Western Kentucky University.
Dr. Chandra Emani, assistant professor of plant molecular biology at WKU-Owensboro, is conducting research on the pharmaceutical and therapeutic benefits of the basil plant. Above he works on samples in his lab at the Owensboro Centre for Business and Research.

Read More... | Comments? | Click here to share, print, or bookmark this photo.



 

































 
 
Quick Links to Popular Features


Looking for a story or picture?
Try our Photo Archive or our Stories Archive for all the information that's appeared on ColumbiaMagazine.com.

 

Contact us: Columbia Magazine and columbiamagazine.com are published by Linda Waggener and Pen Waggener, PO Box 906, Columbia, KY 42728.
Phone: 270.403.0017


Please use our contact page, or send questions about technical issues with this site to webmaster@columbiamagazine.com. All logos and trademarks used on this site are property of their respective owners. All comments remain the property and responsibility of their posters, all articles and photos remain the property of their creators, and all the rest is copyright 1995-Present by Columbia Magazine. Privacy policy: use of this site requires no sharing of information. Voluntarily shared information may be published and made available to the public on this site and/or stored electronically. Anonymous submissions will be subject to additional verification. Cookies are not required to use our site. However, if you have cookies enabled in your web browser, some of our advertisers may use cookies for interest-based advertising across multiple domains. For more information about third-party advertising, visit the NAI web privacy site.